Logo image of CFP.CA

CANFOR CORP (CFP.CA) Stock Fundamental Analysis

TSX:CFP - Toronto Stock Exchange - CA1375761048 - Common Stock - Currency: CAD

14.58  +0.03 (+0.21%)

Fundamental Rating

2

Taking everything into account, CFP scores 2 out of 10 in our fundamental rating. CFP was compared to 12 industry peers in the Paper & Forest Products industry. CFP may be in some trouble as it scores bad on both profitability and health. CFP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CFP has reported negative net income.
CFP had a positive operating cash flow in the past year.
In multiple years CFP reported negative net income over the last 5 years.
In the past 5 years CFP always reported a positive cash flow from operatings.
CFP.CA Yearly Net Income VS EBIT VS OCF VS FCFCFP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

CFP has a Return On Assets of -11.08%. This is in the lower half of the industry: CFP underperforms 66.67% of its industry peers.
CFP's Return On Equity of -19.09% is on the low side compared to the rest of the industry. CFP is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
ROA -11.08%
ROE -19.09%
ROIC N/A
ROA(3y)-1.88%
ROA(5y)5.35%
ROE(3y)-3.36%
ROE(5y)10.62%
ROIC(3y)N/A
ROIC(5y)N/A
CFP.CA Yearly ROA, ROE, ROICCFP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

CFP has a Gross Margin (18.52%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CFP has declined.
The Profit Margin and Operating Margin are not available for CFP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.66%
GM growth 5Y-4.86%
CFP.CA Yearly Profit, Operating, Gross MarginsCFP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

CFP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CFP has been reduced compared to 1 year ago.
Compared to 5 years ago, CFP has less shares outstanding
The debt/assets ratio for CFP is higher compared to a year ago.
CFP.CA Yearly Shares OutstandingCFP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CFP.CA Yearly Total Debt VS Total AssetsCFP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CFP has an Altman-Z score of 1.79. This is a bad value and indicates that CFP is not financially healthy and even has some risk of bankruptcy.
CFP has a Altman-Z score (1.79) which is comparable to the rest of the industry.
CFP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
CFP's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. CFP outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.79
ROIC/WACCN/A
WACC7.05%
CFP.CA Yearly LT Debt VS Equity VS FCFCFP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

CFP has a Current Ratio of 1.77. This is a normal value and indicates that CFP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.77, CFP is in line with its industry, outperforming 41.67% of the companies in the same industry.
CFP has a Quick Ratio of 1.77. This is a bad value and indicates that CFP is not financially healthy enough and could expect problems in meeting its short term obligations.
CFP's Quick ratio of 0.80 is on the low side compared to the rest of the industry. CFP is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 0.8
CFP.CA Yearly Current Assets VS Current LiabilitesCFP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

CFP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.16%.
CFP shows a decrease in Revenue. In the last year, the revenue decreased by -2.51%.
Measured over the past years, CFP shows a small growth in Revenue. The Revenue has been growing by 2.43% on average per year.
EPS 1Y (TTM)-84.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y-11.91%
Revenue growth 5Y2.43%
Sales Q2Q%2.52%

3.2 Future

The Earnings Per Share is expected to grow by 23.88% on average over the next years. This is a very strong growth
Based on estimates for the next years, CFP will show a small growth in Revenue. The Revenue will grow by 5.76% on average per year.
EPS Next Y81.76%
EPS Next 2Y46.33%
EPS Next 3Y34.22%
EPS Next 5Y23.88%
Revenue Next Year2.4%
Revenue Next 2Y5.33%
Revenue Next 3Y6.92%
Revenue Next 5Y5.76%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CFP.CA Yearly Revenue VS EstimatesCFP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CFP.CA Yearly EPS VS EstimatesCFP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CFP. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 26.90, CFP can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CFP is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 21.74. CFP is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 26.9
CFP.CA Price Earnings VS Forward Price EarningsCFP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CFP.CA Per share dataCFP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

CFP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CFP's earnings are expected to grow with 34.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.33%
EPS Next 3Y34.22%

More info and screens

0

5. Dividend

5.1 Amount

CFP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANFOR CORP

TSX:CFP (7/4/2025, 7:00:00 PM)

14.58

+0.03 (+0.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-24 2025-07-24
Inst Owners10.98%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap1.71B
Analysts74
Price Target17.34 (18.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.88%
Min EPS beat(2)2.81%
Max EPS beat(2)22.94%
EPS beat(4)2
Avg EPS beat(4)-37.19%
Min EPS beat(4)-140.33%
Max EPS beat(4)22.94%
EPS beat(8)5
Avg EPS beat(8)-12.9%
EPS beat(12)7
Avg EPS beat(12)-23.03%
EPS beat(16)9
Avg EPS beat(16)-17.71%
Revenue beat(2)2
Avg Revenue beat(2)5.95%
Min Revenue beat(2)2.45%
Max Revenue beat(2)9.46%
Revenue beat(4)4
Avg Revenue beat(4)4.46%
Min Revenue beat(4)1.96%
Max Revenue beat(4)9.46%
Revenue beat(8)8
Avg Revenue beat(8)4.07%
Revenue beat(12)12
Avg Revenue beat(12)5.28%
Revenue beat(16)14
Avg Revenue beat(16)4.47%
PT rev (1m)-2.86%
PT rev (3m)-12.07%
EPS NQ rev (1m)-2.86%
EPS NQ rev (3m)-155.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.9
P/S 0.32
P/FCF N/A
P/OCF 9.29
P/B 0.51
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-3.72
EYN/A
EPS(NY)0.54
Fwd EY3.72%
FCF(TTM)-3.07
FCFYN/A
OCF(TTM)1.57
OCFY10.77%
SpS44.97
BVpS28.31
TBVpS20.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.08%
ROE -19.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.52%
FCFM N/A
ROA(3y)-1.88%
ROA(5y)5.35%
ROE(3y)-3.36%
ROE(5y)10.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.66%
GM growth 5Y-4.86%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 128.54%
Cap/Sales 10.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 0.8
Altman-Z 1.79
F-Score4
WACC7.05%
ROIC/WACCN/A
Cap/Depr(3y)139.97%
Cap/Depr(5y)117.29%
Cap/Sales(3y)9.76%
Cap/Sales(5y)7.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y81.76%
EPS Next 2Y46.33%
EPS Next 3Y34.22%
EPS Next 5Y23.88%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y-11.91%
Revenue growth 5Y2.43%
Sales Q2Q%2.52%
Revenue Next Year2.4%
Revenue Next 2Y5.33%
Revenue Next 3Y6.92%
Revenue Next 5Y5.76%
EBIT growth 1Y-22.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.71%
EBIT Next 3Y40.96%
EBIT Next 5Y25.94%
FCF growth 1Y-783.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.32%
OCF growth 3Y-55.03%
OCF growth 5Y-2.79%